Insulin-like growth factor I activates c-Jun N-terminal kinase in MCF-7 breast cancer cells

Endocrinology

Volumn 141, Issue 2, 2000, Pages 544-550

  Monno, S ^a   Newman, M V ^a   Cook, M ^a   Lowe W L , Jr ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; CYCLIC AMP; FORSKOLIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; SOMATOMEDIN C; STRESS ACTIVATED PROTEIN KINASE;

ARTICLE; BREAST CANCER; CANCER GROWTH; CELL STRAIN MCF 7; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; PHOSPHORYLATION; PRIORITY JOURNAL; REPORTER GENE; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 0034465670     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.141.2.7307     Document Type: Article

References (37)

1. The insulin-like growth factors
2. Insulin-like growth factors and their binding proteins: Biological actions
3. The insulin-like growth factor-I receptor signaling pathways are important for tumorigenesis and inhibition of apoptosis
4. Insulin-like growth factor-I receptor signal transduction: At the interface between physiology and cell biology
5. Mitogen-activated protein kmases: Specific messages from ubiquitous messengers
6. Making the connection: Coupling of stress-activated ERK/MAPK (extracellular-signal-regulated kinase/mitogen-activated protein kinase) core signalling modules to extracellular stimuli and biological responses
7. Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation
8. Sounding the alarm: Protein kinase cascades activated by stress and inflammation
9. Signal transduction by the c-Jun N-terminal kinase
10. The primary structure of p38 γ: A new member of p38 group of MAP kinases
11. Characterization of the structure and function of the fourth member of p38 group mitogen-activated protein kinases, p38delta
12. Growth factor-induced transcription via the serum response element is inhibited by cyclic adenosine 3′,5′-monophosphate in MCF-7 breast cancer cells
13. Phosphatidylinositol 3-kinase mediates epidermal growth factor-induced activation of the c-Jun N-terminal kinase signaling pathway
14. Cyclic AMP inhibition of thrombin-induced growth in vascular smooth muscle cells correlates with decreased JNK1 activity and c-Jun expression
15. The p70S6K signalling pathway: A novel signalling system involved in growth regulation
16. Up-regulation of insulin-like growth factor binding protein-5 is independent of muscle cell differentiation, sensitive to rapamycin, but insensitive to wortmannin and LY294002
17. The insulin-like growth factor system as a target in breast cancer
18. Growth factors in breast cancer
19. Mitogenic signaling of insulin-like growth factor I in MCF-7 human breast cancer cells requires phosphatidylinositol 3-kinase and is independent of mitogen-activated protein kinase
20. Insulin receptor substrate-1 is the predominant signaling molecule activated by insulin-like growth factor-I, insulin, and interleukin-4 in estrogen receptor-positive human breast cancer cells
21. The serum response element
22. Ternary complex factors: Growth factor regulated transcriptional activators
23. Protein synthesis inhibitors reveal differential regulation of mitogen-activated protein kinase and stress-activated protein kinase pathways that converge on Elk-1
24. Integration of MAP kinase signal transduction pathways at the serum response element
25. Evidence for separate mechanisms of antiproliferative action of indomethacin and prostaglandin on MCF-7 breast cancer cells
26. 1/S transition in mammary carcinoma cells (MCF-7)
27. 1
28. Thyrotropin regulates c-Jun N-terminal kinase (JNK) activity through two distinct signal pathways in human thyroid cells
29. Bidirectional regulation of p38 kinase and c-Jun N-terminal protein kinase by insulin-like growth factor-I
30. Insulin-like growth factor-I inhibits the stress-activated protein kinase/c-Jun N-terminal kinase
31. Jun N-terminal kinase mediates activation of skeletal muscle glycogen synthase by insulin in vivo
32. RO 318220 activates c-Jun N-terminal kinase and glycogen synthase in rat adipocytes and L6 myotubes. Comparison to actions of insulin
33. SOS phosphorylation and disassociation of the Grb2-SOS complex by the ERK and JNK signaling pathways
34. Regulation of phosphorylation pathways by p21 GTPases. The p21 Ras-related Rho subfamily and its role in phosphorylation signalling pathways
35. Replacement of tyrosine 1251 in the carboxyl terminus of the insulin-like growth factor-I receptor disrupts the actin cytoskeleton and inhibits proliferation and anchorage-independent growth
36. Insulin-like growth factor I stimulates tyrosine phosphorylation of p130(Cas), focal adhesion kinase, and paxillin. Role of phosphatidylinositol 3′-kinase and formation of a p130(Cas). Crk complex
37. Concerted activity of tyrosine phosphatase SHP-2 and focal adhesion kinase in regulation of cell motility